Processing

Please wait...

Settings

Settings

Goto Application

1. US20130281701 - CRYSTAL FORMS OF ANAMORELIN

Office
United States of America
Application Number 13919518
Application Date 17.06.2013
Publication Number 20130281701
Publication Date 24.10.2013
Publication Kind A1
IPC
C07D 401/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
CPC
C07D 401/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
06linked by a carbon chain containing only aliphatic carbon atoms
Applicants Lorimer Keith
Helsinn Therapeutics (U.S.), Inc.
Philipson Marcia
Paul Bernhard
Littler Benjamin
Inventors Lorimer Keith
Pines Seemon H.
Philipson Marcia
Paul Bernhard
Littler Benjamin
Title
(EN) CRYSTAL FORMS OF ANAMORELIN
Abstract
(EN)

Crystalline forms of anamorelin which are useful as pharmaceutical agents are disclosed. Methods of production and isolation of these polymorphs and pharmaceutical compositions which include these polymorphs and pharmaceutical methods of treatment are also disclosed. The crystalline polymorphs of the present invention are useful as they act directly on the pituitary gland cells to release growth hormone.


Related patent documents